Risultati della ricerca - Роберто Пили
- Mostra 1 - 20 risultati su 79
- Vai alla pagina seguente
-
1
Class I histone deacetylase inhibition is a novel mechanism to target regulatory T cells in immunotherapy di Li Shen, Роберто Пили
Pubblicazione 2012Artigo -
2
-
3
Targeting tumor angiogenesis with histone deacetylase inhibitors di Leigh Ellis, Hans J. Hammers, Роберто Пили
Pubblicazione 2008Revisão -
4
Mechanisms of action of tasquinimod on the tumour microenvironment di Éric Raymond, Angus Dalgleish, J.‐E. Damber, Matthew R. Smith, Роберто Пили
Pubblicazione 2013Revisão -
5
-
6
Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor... di Sreenivasulu Chintala, Tanbir Najrana, Károly Tóth, Shousong Cao, Farukh A. Durrani, Роберто Пили, Youcef M. Rustum
Pubblicazione 2012Artigo -
7
Telemedicine, e-Health, and Digital Health Equity: A Scoping Review di Донателла Рита Петретто, Gian Pietro Carrogu, Luca Gaviano, Roberta Berti, Martina Pinna, A Petretto, Роберто Пили
Pubblicazione 2024Revisão -
8
-
9
The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic... di Daniel Keizman, Maya Ish‐Shalom, Peng Huang, Mario A. Eisenberger, Роберто Пили, Hans J. Hammers, Michael A. Carducci
Pubblicazione 2011Artigo -
10
Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours di Роберто Пили, Brenda Salumbides, Ming Zhao, Soner Altiok, David Z. Qian, James A. Zwiebel, Michael A. Carducci, Michelle A. Rudek
Pubblicazione 2011Artigo -
11
Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: A retrospective examination di Daniel Keizman, Peng Huang, Mario A. Eisenberger, Роберто Пили, Jenny J. Kim, Emmanuel S. Antonarakis, Hans J. Hammers, Michael A. Carducci
Pubblicazione 2011Artigo -
12
-
13
Nanosponge-encapsulated camptothecin exerts anti-tumor activity in human prostate cancer cells di Rosalba Minelli, Roberta Cavalli, Leigh Ellis, Piergiorgio Pettazzoni, Francesco Trotta, Eric Ciamporcero, Giuseppina Barrera, Roberto Fantozzi, Chiara Dianzani, Роберто Пили
Pubblicazione 2012Artigo -
14
Restriction of dietary protein decreases mTORC1 in tumors and somatic tissues of a tumor-bearing mouse xenograft model di Dudley W. Lamming, Nicole E. Cummings, Antonella Rastelli, Feng Gao, Edda Cava, Beatrice Bertozzi, Francesco Spelta, Роберто Пили, Luigi Fontana
Pubblicazione 2015Artigo -
15
Class I Histone Deacetylase Inhibitor Entinostat Suppresses Regulatory T Cells and Enhances Immunotherapies in Renal and Prostate Cancer Models di Li Shen, Michael J. Ciesielski, Swathi Ramakrishnan, Kiersten Marie Miles, Leigh Ellis, Paula Sotomayor, Protul Shrikant, Robert A. Fenstermaker, Роберто Пили
Pubblicazione 2012Artigo -
16
Combination Strategy Targeting the Hypoxia Inducible Factor-1α with Mammalian Target of Rapamycin and Histone Deacetylase Inhibitors di Henk M.W. Verheul, Brenda Salumbides, Karen van Erp, Hans J. Hammers, David Z. Qian, Tolib B. Sanni, Peter Atadja, Роберто Пили
Pubblicazione 2008Artigo -
17
Antitumor effect of the histone deacetylase inhibitor LAQ824 in combination with 13-<i>cis</i>-retinoic acid in human malignant melanoma di Yukihiko Kato, Brenda Salumbides, Xiao-Fei Wang, David Z. Qian, Simon A. Williams, Yongfeng Wei, Tolib B. Sanni, Peter Atadja, Роберто Пили
Pubblicazione 2007Artigo -
18
Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer di Eric Ciamporcero, Martina Daga, Stefania Pizzimenti, Antonella Roetto, Chiara Dianzani, Alessandra Compagnone, A Palmieri, Chiara Ullio, Luigi Cangemi, Роберто Пили, Giuseppina Barrera
Pubblicazione 2017Artigo -
19
Data-Independent Acquisition Phosphoproteomics of Urinary Extracellular Vesicles Enables Renal Cell Carcinoma Grade Differentiation di Marco Hadisurya, Zheng-Chi Lee, Zhuojun Luo, Guiyuan Zhang, Yajie Ding, Hao Zhang, Anton Iliuk, Роберто Пили, Ronald S. Boris, W. Andy Tao
Pubblicazione 2023Artigo -
20
Dietary protein restriction inhibits tumor growth in human xenograft models of prostate and breast cancer di Luigi Fontana, Remi Adelaiye‐Ogala, Antonella Rastelli, Kiersten Marie Miles, Eric Ciamporcero, Valter D. Longo, Holly M. Nguyen, Robert L. Vessella, Роберто Пили
Pubblicazione 2013Artigo
Strumenti per la ricerca:
Soggetti correlati
Medicine
Internal medicine
Cancer
Oncology
Cancer research
Biology
Biochemistry
Gene
Renal cell carcinoma
Prostate cancer
Sunitinib
Chemistry
Genetics
Pharmacology
Pathology
Histone
Histone deacetylase
Angiogenesis
Cell biology
Gastroenterology
Adverse effect
Chemotherapy
Urology
Apoptosis
Progression-free survival
Clinical endpoint
Clinical trial
Immunology
Immune system
In vitro